A citation-based method for searching scientific literature

Young Shin Song, Jung Ah Lim, Hoonsung Choi, Jae-Kyung Won, Jae Hoon Moon, Sun Wook Cho, Kyu Eun Lee, Young Joo Park, Ka Hee Yi, Do Joon Park, Jeong-Sun Seo. Cancer 2016
Times Cited: 89







List of shared articles



Times cited

Prognostic implication of BRAF and TERT promoter mutation combination in papillary thyroid carcinoma-A meta-analysis.
Huy Gia Vuong, Ahmed M A Altibi, Uyen N P Duong, Lewis Hassell. Clin Endocrinol (Oxf) 2017
48

Interaction of BRAF-induced ETS factors with mutant TERT promoter in papillary thyroid cancer.
Young Shin Song, Seong-Keun Yoo, Hwan Hee Kim, Gyeongseo Jung, Ah-Reum Oh, Ji-Young Cha, Su-Jin Kim, Sun Wook Cho, Kyu Eun Lee, Jeong-Sun Seo,[...]. Endocr Relat Cancer 2019
24

The Coexistence of Genetic Mutations in Thyroid Carcinoma Predicts Histopathological Factors Associated With a Poor Prognosis: A Systematic Review and Network Meta-Analysis.
Ling Zhao, Lin Wang, Xiaomeng Jia, Xiaodong Hu, Ping Pang, Sitong Zhao, Yajing Wang, Jing Wang, Yingshi Zhang, Zhaohui Lyu. Front Oncol 2020
3

A meta-analysis of prognostic roles of molecular markers in papillary thyroid carcinoma.
Huy Gia Vuong, Uyen N P Duong, Ahmed M A Altibi, Hanh T T Ngo, Thong Quang Pham, Hung Minh Tran, Greta Gandolfi, Lewis Hassell. Endocr Connect 2017
34

Prognostic Parameters in Differentiated Thyroid Carcinomas.
Nicole A Cipriani. Surg Pathol Clin 2019
7

Clinical utility of EZH1 mutations in the diagnosis of follicular-patterned thyroid tumors.
Chan Kwon Jung, Yourha Kim, Sora Jeon, Kwanhoon Jo, Sohee Lee, Ja Seong Bae. Hum Pathol 2018
25


Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer.
Rengyun Liu, Tao Zhang, Guangwu Zhu, Mingzhao Xing. Nat Commun 2018
80


Differences in Gene Expression Profile of Primary Tumors in Metastatic and Non-Metastatic Papillary Thyroid Carcinoma-Do They Exist?
Sylwia Szpak-Ulczok, Aleksandra Pfeifer, Dagmara Rusinek, Malgorzata Oczko-Wojciechowska, Malgorzata Kowalska, Tomasz Tyszkiewicz, Marta Cieslicka, Daria Handkiewicz-Junak, Krzysztof Fujarewicz, Dariusz Lange,[...]. Int J Mol Sci 2020
3

Highly prevalent BRAF V600E and low-frequency TERT promoter mutations underlie papillary thyroid carcinoma in Koreans.
Sue Youn Kim, Taeeun Kim, Kwangsoon Kim, Ja Seong Bae, Jeong Soo Kim, Chan Kwon Jung. J Pathol Transl Med 2020
7

A six-genotype genetic prognostic model for papillary thyroid cancer.
Xiaopei Shen, Rengyun Liu, Mingzhao Xing. Endocr Relat Cancer 2017
41

TERT biology and function in cancer: beyond immortalisation.
Ana Pestana, João Vinagre, Manuel Sobrinho-Simões, Paula Soares. J Mol Endocrinol 2017
36

Mechanisms of TERT Reactivation and Its Interaction with BRAFV600E.
Young Shin Song, Young Joo Park. Endocrinol Metab (Seoul) 2020
2

Role of molecular markers to predict distant metastasis in papillary thyroid carcinoma: Promising value of TERT promoter mutations and insignificant role of BRAF mutations-a meta-analysis.
Huy Gia Vuong, Ahmed Ma Altibi, Uyen Np Duong, Hanh Tt Ngo, Thong Quang Pham, Hung Minh Tran, Naoki Oishi, Kunio Mochizuki, Tadao Nakazawa, Lewis Hassell,[...]. Tumour Biol 2017
23

Telomerase Reverse Transcriptase (TERT) Regulation in Thyroid Cancer: A Review.
Brittany A McKelvey, Christopher B Umbricht, Martha A Zeiger. Front Endocrinol (Lausanne) 2020
6

The Combination of RET, BRAF and Demographic Data Identifies Subsets of Patients with Aggressive Papillary Thyroid Cancer.
Jose R W Martínez, Sergio Vargas-Salas, Soledad Urra Gamboa, Estefanía Muñoz, José Miguel Domínguez, Augusto León, Nicolás Droppelmann, Antonieta Solar, Mark Zafereo, F Christopher Holsinger,[...]. Horm Cancer 2019
4

How limited molecular testing can also offer diagnostic and prognostic evaluation of thyroid nodules processed with liquid-based cytology: Role of TERT promoter and BRAF V600E mutation analysis.
Marco Dell'Aquila, Vincenzo Fiorentino, Maurizio Martini, Sara Capodimonti, Tonia Cenci, Celestino Pio Lombardi, Marco Raffaelli, Alfredo Pontecorvi, Guido Fadda, Liron Pantanowitz,[...]. Cancer Cytopathol 2021
0


Molecular Profile of Locally Aggressive Well Differentiated Thyroid Cancers.
Leila J Mady, Michael C Grimes, Nayel I Khan, R Harsha Rao, Simion I Chiosea, Linwah Yip, Robert L Ferris, Yuri E Nikiforov, Sally E Carty, Umamaheswar Duvvuri. Sci Rep 2020
2


The ETS Inhibitor YK-4-279 Suppresses Thyroid Cancer Progression Independent of TERT Promoter Mutations.
Junyu Xue, Shiyong Li, Peijie Shi, Mengke Chen, Shuang Yu, Shubin Hong, Yanbing Li, Rengyun Liu, Haipeng Xiao. Front Oncol 2021
1

Genomic Characterization of Differentiated Thyroid Carcinoma.
Young Shin Song, Young Joo Park. Endocrinol Metab (Seoul) 2019
18

Impact of BRAF V600E and TERT Promoter Mutations on Response to Therapy in Papillary Thyroid Cancer.
Tomasz Trybek, Agnieszka Walczyk, Danuta Gąsior-Perczak, Iwona Pałyga, Estera Mikina, Artur Kowalik, Kinga Hińcza, Janusz Kopczyński, Magdalena Chrapek, Stanisław Góźdź,[...]. Endocrinology 2019
10

TERT promoter mutation in primary papillary thyroid carcinoma lesions predicts absent or lower 131 i uptake in metastases.
Zhaowei Meng, Michiko Matsuse, Vladimir Saenko, Shunichi Yamashita, Peng Ren, Xiangqian Zheng, Qiang Jia, Jian Tan, Ning Li, Wei Zheng,[...]. IUBMB Life 2019
5

Genetic-guided Risk Assessment and Management of Thyroid Cancer.
Mingzhao Xing. Endocrinol Metab Clin North Am 2019
18